Tablet Health Review
Best for: Patients comfortable with a new operation (copyright 2026) who want LegitScript certification + four named non-warning-lettered compounder partners + an oral GLP-1 option, AND who are willing to complete the intake quiz to learn state eligibility and dose-tier pricing.
DTC telehealth (Tablet, LLC / Tablet Telehealth Corp, copyright 2026 — new operation) offering compounded semaglutide and tirzepatide in both injection and oral form. Starting prices: oral semaglutide $179/mo, compounded semaglutide injection $199/mo, oral tirzepatide $199/mo, compounded tirzepatide injection $299/mo. LegitScript Certified (cert 70456). Four named partner pharmacies disclosed (The Pharmacy Hub Miami FL, Epiq Scripts Richardson TX, Dr. TelX Kennewick WA, Emerad Compounding Tampa FL) with no FDA warning letters against any. CAUTION: state coverage not publicly published, no founder/PIC/medical director named, no BBB profile, Tablet Pharmacy NYC brick-and-mortar 'opening soon' (not yet operating). Multi-vertical platform also covers ED treatment and NAD+ wellness.
Low confidence · Last verified 2026-05-30 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Tablet Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Tablet Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Starting (dose tier unpublished) | compounded | $199 |
| Starting oral (dose tier unpublished) | compounded | $179 |
| Starting (dose tier unpublished) | compounded | $299 |
| Starting oral (dose tier unpublished) | compounded | $199 |
✓ Pros
- •LegitScript Certified (cert 70456)
- •Four named compounding pharmacy partners — none with FDA warning letters as of 2026-05-30: The Pharmacy Hub (Miami FL), Epiq Scripts (Richardson TX, NPI 1790415883, 503A state-licensed), Dr. TelX LLC (Kennewick WA), Emerad Compounding Pharmacy (Tampa FL)
- •Oral GLP-1 option available (both semaglutide and tirzepatide) — uncommon in the compounded telehealth category
- •Mid-tier pricing: starting $179-$299/mo across all four product variants
- •No commitment / cancel anytime model
✗ Cons
- •STATE COVERAGE NOT PUBLISHED — Terms of Service mention service is limited to certain states but no list disclosed; patients must complete intake quiz to learn eligibility
- •NO FOUNDER, CEO, MEDICAL DIRECTOR, OR PHARMACIST-IN-CHARGE NAMED on the website, Terms of Service, or any indexed search result
- •NO BBB PROFILE found for 'Tablet Health' or 'Tablet Telehealth Corp' as of 2026-05-30
- •Tablet Pharmacy Queens NYC brick-and-mortar is 'opening soon' per the site — not currently operating; all dispensing today routes through four external compounder partners
- •Copyright year 2026 in footer indicates very young operation with no multi-year track record
- •Dose-tier pricing breakdown is gated behind the intake quiz — no public price list per dose mg
- •Compounded medications are not FDA-approved
- •Email-only support (support@tablethealth.com); no phone number published
Ready to start with Tablet Health?
Starting at $179/month. See current pricing and start your free consultation.
Sources & methodology
Our Tablet Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Tablet Health
Belle Health
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-oriented patients who want compounded GLP-1 alongside hormone and performance programs from a 25-year-old established brand
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Tablet Health?
Starting at $179/month. See current pricing and start your free consultation.